558 related articles for article (PubMed ID: 9921809)
21. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
22. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
[TBL] [Abstract][Full Text] [Related]
23. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
[TBL] [Abstract][Full Text] [Related]
24. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
25. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
[TBL] [Abstract][Full Text] [Related]
26. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
27. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
Saitovitch D; Morris PJ; Wood KJ
Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
[TBL] [Abstract][Full Text] [Related]
28. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
[TBL] [Abstract][Full Text] [Related]
29. Rejection of kidney allografts by MHC class I-deficient mice.
Mannon RB; Nataraj C; Kotzin BL; Griffiths R; Geier S; Ibrahim S; Sanfilippo FP; Platt JL; Kurlander R; Coffman TM
Transplantation; 1995 Mar; 59(5):746-55. PubMed ID: 7886804
[TBL] [Abstract][Full Text] [Related]
30. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
[TBL] [Abstract][Full Text] [Related]
31. CD4+ but not CD8+ cells are essential for allorejection.
Krieger NR; Yin DP; Fathman CG
J Exp Med; 1996 Nov; 184(5):2013-8. PubMed ID: 8920888
[TBL] [Abstract][Full Text] [Related]
32. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
33. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
34. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
[TBL] [Abstract][Full Text] [Related]
35. CD4+ T-cell-independent rejection of corneal allografts.
Niederkorn JY; Stevens C; Mellon J; Mayhew E
Transplantation; 2006 Apr; 81(8):1171-8. PubMed ID: 16641604
[TBL] [Abstract][Full Text] [Related]
36. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Bonavida B; Ardehali A
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):803-9. PubMed ID: 11986610
[TBL] [Abstract][Full Text] [Related]
37. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
[TBL] [Abstract][Full Text] [Related]
39. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
[TBL] [Abstract][Full Text] [Related]
40. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
